08.03.2023 • NewsSafic-AlcanKunststoffe & Polymere

Safic-Alcan Acquires Plastics Distributor 4PLAS

Independent French specialty chemicals distributor Safic-Alcan has acquired UK engineering plastics distributor 4PLAS for an undisclosed sum.

The British company with 11 employees and sales of £ 13.5 million supplies polymer solutions to the injection moulding industry in the UK and Ireland. Its portfolio extends to masterbatches and color & custom compounds, as well as its high performance materials and  additives & fillers.

With this acquisition, its fifth in the UK over the past 15 years, Safic-Alcan said the UK country will become one of its main regions for plastics distribution, which currently account for 5% of  its sales.

© Shutterstock/Cavava
© Shutterstock/Cavava

The French distributor’s portfolio also encompasses a wide ranges of polymers, materials and additives for the rubber, coatings, adhesives, thermoplastics, polyurethane, lubricants, detergency, cosmetics,  pharmaceuticals and nutraceuticals industries.

In another acquisition, Safic-Alcan has taken 100% control of PNP, an Italian distributor with a strong presence in dairy and food ingredients. The latest deal in this sector will complement the business of Castelli Food, which Safic-Alcan acquired in 2019.

Author: Dede Williams, Freelance Journalist

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.